PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29391764-1	2018	AIM: To optimize the hepatobiliary phase delay time (HBP-DT) of Gd-EOB-DTPA-enhanced magnetic resonance imaging (GED-MRI) for more efficient identification of hepatocellular carcinoma (HCC) occurring in different degrees of cirrhosis assessed by Child-Pugh (CP) score.	gadolinium ethoxybenzyl DTPA	64-75	heme binding protein 1	Homo sapiens	53-56	
29254310-1	2017	The aim of this study was to investigate the value of Gd-EOB-DTPA-enhanced MRI on hepatobiliary phase (HBP) imaging and T1 mapping sequence in the differentiation of hepatocellular carcinoma (HCC).	gadolinium ethoxybenzyl DTPA	54-65	heme binding protein 1	Homo sapiens	103-106	
29254310-16	2017	T1 mapping in pre-contrast and HBP of Gd-EOB-DTPA-enhanced MRI, a non-smooth tumor margin in the HBP of Gd-EOB-DTPA-enhanced MRI, are useful in predicting the pathologic grading of HCC.	gadolinium ethoxybenzyl DTPA	38-49	heme binding protein 1	Homo sapiens	31-34	
29254310-16	2017	T1 mapping in pre-contrast and HBP of Gd-EOB-DTPA-enhanced MRI, a non-smooth tumor margin in the HBP of Gd-EOB-DTPA-enhanced MRI, are useful in predicting the pathologic grading of HCC.	gadolinium ethoxybenzyl DTPA	38-49	heme binding protein 1	Homo sapiens	97-100	
29254310-16	2017	T1 mapping in pre-contrast and HBP of Gd-EOB-DTPA-enhanced MRI, a non-smooth tumor margin in the HBP of Gd-EOB-DTPA-enhanced MRI, are useful in predicting the pathologic grading of HCC.	gadolinium ethoxybenzyl DTPA	104-115	heme binding protein 1	Homo sapiens	97-100